Neuropsychiatric Drug Development Summit 2026: Advancing the Next Generation of Precision Psychiatry
The 9th Neuropsychiatric Drug Development Summit is the leading industry forum dedicated to accelerating innovation in mental health therapeutics. Bringing together more than 150 leaders from biopharma, biotech, academia, clinical research, and regulatory organisations, the summit explores the latest advances in precision psychiatry, neuroplastogens, biomarkers, patient stratification, and translational neuroscience. With a focus on overcoming the challenges of neuropsychiatric drug development and improving clinical outcomes, the event provides a unique platform for collaboration, scientific exchange, and the advancement of next-generation therapies for conditions including depression, schizophrenia, PTSD, addiction, and anxiety disorders.
View Event
